Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162383 | SCV000212696 | benign | Hereditary cancer-predisposing syndrome | 2014-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000241658 | SCV000303564 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000380108 | SCV000365715 | likely benign | PTEN hamartoma tumor syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000241658 | SCV000596617 | benign | not specified | 2019-01-09 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000241658 | SCV000691987 | likely benign | not specified | no assertion criteria provided | clinical testing |